{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:06:06Z","timestamp":1765173966202,"version":"3.46.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00786-1","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T06:15:33Z","timestamp":1763878533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients with inflammatory bowel disease exhibit increased susceptibility to HCoV-NL63"],"prefix":"10.1186","volume":"17","author":[{"given":"Tingting","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"issue":"5","key":"786_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/irv.12563","volume":"12","author":"BM Davis","year":"2018","unstructured":"Davis BM, et al. Human coronaviruses and other respiratory infections in young adults on a university campus: prevalence, symptoms, and shedding. Influenza Other Respir Viruses. 2018;12(5):582\u201390.","journal-title":"Influenza Other Respir Viruses"},{"issue":"4 Pt B","key":"786_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/135965350701200S01.1","volume":"12","author":"L van der Hoek","year":"2007","unstructured":"van der Hoek L. Human coronaviruses: what do they cause? Antivir Ther. 2007;12(4 Pt B):651\u20138.","journal-title":"Antivir Ther"},{"issue":"6","key":"786_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1086\/597122","volume":"199","author":"GJ Gorse","year":"2009","unstructured":"Gorse GJ, et al. Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease. J Infect Dis. 2009;199(6):847\u201357.","journal-title":"J Infect Dis"},{"issue":"4","key":"786_CR4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202820120","volume":"120","author":"D Liu","year":"2023","unstructured":"Liu D, et al. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. Proc Natl Acad Sci U S A. 2023;120(4):e2202820120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"786_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.18683\/germs.2022.1331","volume":"12","author":"CC Paredes-Amaya","year":"2022","unstructured":"Paredes-Amaya CC, Matta-Cortes L, Zea-Vera AF. Severe coronavirus HCoV-NL63 pneumonia in a patient receiving blinatumomab with secondary antibody deficiency in COVID-19 times. Germs. 2022;12(2):292\u20137.","journal-title":"Germs"},{"issue":"3","key":"786_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jmv.20288","volume":"75","author":"KE Arden","year":"2005","unstructured":"Arden KE, et al. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol. 2005;75(3):455\u201362.","journal-title":"J Med Virol"},{"issue":"1","key":"786_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","volume":"20","author":"KL Wallace","year":"2014","unstructured":"Wallace KL. Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014;20(1):6\u201321.","journal-title":"World J Gastroenterol"},{"key":"786_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","volume":"71\u201372","author":"J Liu","year":"2023","unstructured":"Liu J, Di B, L Xu L. Recent advances in the treatment of IBD: Targets, mechanisms and related therapies. Cytokine Growth Factor Rev. 2023;71\u201372:1\u201312.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"786_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, et al. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"786_CR10","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.0409465102","volume":"102","author":"H Hofmann","year":"2005","unstructured":"Hofmann H, et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A. 2005;102(22):7988\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"786_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-00139-y","volume":"5","author":"C Liu","year":"2021","unstructured":"Liu C, et al. High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients. NPJ Precis Oncol. 2021;5(1):1.","journal-title":"NPJ Precis Oncol"},{"issue":"8","key":"786_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3201\/eid1108.050110","volume":"11","author":"A Vabret","year":"2005","unstructured":"Vabret A, et al. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11(8):1225\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"786_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcv.2010.02.013","volume":"48","author":"M Risku","year":"2010","unstructured":"Risku M, et al. Detection of human coronaviruses in children with acute gastroenteritis. J Clin Virol. 2010;48(1):27\u201330.","journal-title":"J Clin Virol"},{"key":"786_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1743-422X-5-138","volume":"5","author":"P Herzog","year":"2008","unstructured":"Herzog P, Drosten C, Muller MA. Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J. 2008;5:138.","journal-title":"Virol J"},{"issue":"1","key":"786_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF Chan","year":"2020","unstructured":"Chan JF, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221\u201336.","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"786_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, et al. The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226\u201336.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"786_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F. Structure, function, and evolution of coronavirus Spike proteins. Annu Rev Virol. 2016;3(1):237\u201361.","journal-title":"Annu Rev Virol"},{"issue":"11","key":"786_CR18","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie J, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020;15(11):3699\u2013715.","journal-title":"Nat Protoc"},{"issue":"13","key":"786_CR19","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117(13):7001\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"786_CR20","unstructured":"Matumoto M, - A note on some points of calculation method of LD50 by Reed and muench. - Jpn J Exp Med. 1949;20(2):175\u20139., 1949(\u2013\u20090021-5031 (Print)): p. \u2013\u2009175-9."},{"issue":"6","key":"786_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","volume":"15","author":"T Kucharzik","year":"2021","unstructured":"Kucharzik T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15(6):879\u2013913.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"786_CR22","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler CGK, et al. SARS-CoV-2 receptor ACE2 is an Interferon-Stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016\u2013e103519.","journal-title":"Cell"},{"issue":"13","key":"786_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108199","volume":"32","author":"L Hennighausen","year":"2020","unstructured":"Hennighausen L, Lee HK. Activation of the SARS-CoV-2 receptor Ace2 through JAK\/STAT-dependent enhancers during pregnancy. Cell Rep. 2020;32(13):108199.","journal-title":"Cell Rep"},{"key":"786_CR24","doi-asserted-by":"publisher","first-page":"890782","DOI":"10.3389\/fmed.2022.890782","volume":"9","author":"T Chen","year":"2022","unstructured":"Chen T, et al. ACE2 promoted by STAT3 activation has a protective role in Early-Stage acute kidney injury of murine sepsis. Front Med (Lausanne). 2022;9:890782.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"786_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiab089","volume":"223","author":"J Ringlander","year":"2021","unstructured":"Ringlander J, et al. Incidence and severity of Covid-19 in patients with and without previously verified infections with common cold coronaviruses. J Infect Dis. 2021;223(10):1831\u20132.","journal-title":"J Infect Dis"},{"key":"786_CR26","doi-asserted-by":"crossref","unstructured":"Sermet-Gaudelus I, et al. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020. Euro Surveill. 2021;26(13):2001782.","DOI":"10.2807\/1560-7917.ES.2021.26.13.2001782"},{"key":"786_CR27","doi-asserted-by":"crossref","unstructured":"Simula ER, et al. HCoV-NL63 and SARS-CoV-2 share recognized epitopes by the humoral response in sera of people collected pre- and during CoV-2 pandemic. Microorganisms. 2020;8(12):1993.","DOI":"10.3390\/microorganisms8121993"},{"issue":"9","key":"786_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol. 2002;2(9):706\u201313.","journal-title":"Nat Rev Immunol"},{"issue":"32","key":"786_CR29","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle KA, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423\u20138.","journal-title":"Vaccine"},{"issue":"7","key":"786_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055\u201365.","journal-title":"Clin Vaccine Immunol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00786-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:04:47Z","timestamp":1765173887000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00786-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00786-1","relation":{},"ISSN":["1757-4749"],"issn-type":[{"type":"electronic","value":"1757-4749"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical samples used in this study were collected from patients undergoing colonoscopy at Department of Gastroenterology, Beijing Friendship Hospital, between January 2017 and June 2018, with informed consent. The study protocol was approved by the Ethics Committee of Beijing Friendship Hospital (Approval No. 2018-P2-058-01), and all procedures conformed to the Declaration of Helsinki. The animal study was approved by the Institutional Animal Care and Use Committee of Capital Medical University. All animals were housed in accordance with relevant guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ACE2 was increased in the colon from IBD patients. Inflammatory IECs were more susceptible to pseudotyped HCoV-NL63. Besides, reduced protective neutralizing antibody titers were seen in IBD patients, suggesting that IBD patients may be particularly susceptible to HCoV-NL63 infection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Summary"}}],"article-number":"101"}}